• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT HIV AG/AB COMBO REAGENT KIT; TEST, HIV DETECTION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT HIV AG/AB COMBO REAGENT KIT; TEST, HIV DETECTION Back to Search Results
Catalog Number 04J27-89
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/29/2023
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A final report will be submitted when the evaluation is complete.Section e1 - phone number complete entry = (b)(6).Section e1 - address 1 complete entry = (b)(6).All available patient information was included.Additional patient details are not available.
 
Event Description
The customer observed a false non-reactive architect hiv ag/ab result generated on a 28-year-old pregnant female patient sample.The following data was provided (reference range <1.00 is non-reactive): colloidal gold initial = positive, then tested on the architect and result = 0.23 s/co, sample centrifuged and retested.Result = non-reactive.Repeat colloidal gold = positive, and negative.No impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and in-house testing of a retained reagent kit.Return testing was not completed as returns were not available.A review of tracking and trending did not identify any trends for the issue for the product.Device history record review for lot 54530be00 did not identify any non-conformances or deviations with the complaint lot.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.In-house testing of a retained reagent kit of the complaint lot was performed.All specifications were met, and no false reactive results were obtained, indicating that the lot generates the expected results.In addition, the clinical sensitivity of the lot was evaluated by testing two commercially available seroconversion panels.The lot detected the same bleeds as reactive for the seroconversion panels, which indicates the sensitivity performance of the complaint lot is not negatively affected.Labeling was reviewed and sufficiently addresses the customer's issue.Based on the investigation, no systemic issue or deficiency with the architect hiv ag/ab reagent lot number 54530be00, was identified.
 
Event Description
The customer observed a false non-reactive architect hiv ag/ab result generated on a 28-year-old pregnant female patient sample.The following data was provided (reference range <1.00 is non-reactive): colloidal gold initial = positive, then tested on the architect and result = 0.23 s/co, sample centrifuged and retested.Result = non-reactive.Repeat colloidal gold = positive, and negative.No impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HIV AG/AB COMBO REAGENT KIT
Type of Device
TEST, HIV DETECTION
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key18110349
MDR Text Key328024100
Report Number3002809144-2023-00464
Device Sequence Number1
Product Code MZF
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/10/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/25/2024
Device Catalogue Number04J27-89
Device Lot Number54530BE00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/24/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/13/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2000SR INST, 03M74-02, (B)(6); ARC I2000SR INST, 03M74-02, (B)(6)
-
-